HPN536

· Harpoon Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HPN536, covering 2024-06-07 to 2024-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression [Phase 1]